A PYMNTS Company

France: More woes for Novartis, Roche after Italy fine

By  |  March 12, 2014

Pharmaceutical rivals Novartis and Roche are facing an antirust investigation in France just days after Italian regulators fined the companies for alleged collusion.

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    yesSubscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

    Reports say the Swiss rivals were accused of colluding to prevent the use of a cancer drug made by Roche for use to treat an eye disease. Specifically, the companies are said to have blocked that drug’s distribution in favor of a more expensive drug marketed by both companies.

    After Italy fined the companies, reports say France’s Health Ministry sought an investigation into the matter by the Finance Ministry; regulators confirmed the investigation is “ongoing.”

    Full Content: Bloomberg

    Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.